QA: Meridian Bioscience INC in us_medicinal_products/2011

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000794172_2012_Meridian_Bioscience_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.19316358109560688, 'aggregate_val': 161381000, 'exp_sum': 200017000, 'exp_to_value': {'AssetsCurrent': 96590000, 'AssetsNoncurrent': 38636000, 'PropertyPlantAndEquipmentNet': 26155000, 'Goodwill': 33410000, 'remainder_Assets': 5226000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.1988737357864529, 'aggregate_val': 155493000, 'exp_sum': 194093000, 'exp_to_value': {'AssetsCurrent': 90354000, 'AssetsNoncurrent': 38600000, 'PropertyPlantAndEquipmentNet': 26539000, 'Goodwill': 34071000, 'remainder_Assets': 4529000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000794172')"}

Graph

Absolute values for 0000794172, Meridian Bioscience INC

  xvar xval
0 LiabilitiesNoncurrent 0
1 LiabilitiesCurrent 15,264,000
2 remainder_Liabilities 0
3 AssetsCurrent 90,354,000
4 AssetsNoncurrent 38,600,000
5 PropertyPlantAndEquipmentNet 26,539,000
6 Goodwill 34,071,000
7 remainder_Assets -34,071,000
8 GeneralAndAdministrativeExpense 47,655,000
9 ResearchAndDevelopmentExpense 9,822,000
10 remainder_Expenses 75,882,000
11 remainder_Revenues 159,723,000
12 remainder_NetIncome 467,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Liabilities 15,264,000
1 Assets 155,493,000
2 Expenses 133,359,000
3 Revenues 159,723,000
4 StockholdersEquity 140,229,000
5 NetIncome 26,831,000
6 ComprehensiveNetIncome 26,831,000
7 BaseVar 232,153,000
8 EconomicCapitalRatiobeforeLimitedLiability 2.56
9 EconomicCapitalRatio 2.76

Edgar->Model Mapping

Feature Distribution

Change over Time